Greenwich LifeSciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GLSI and other ETFs, options, and stocks.About GLSI
Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.
CEOSnehal S. Patel
CEOSnehal S. Patel
Employees8
Employees8
HeadquartersStafford, Texas
HeadquartersStafford, Texas
Founded2006
Founded2006
Employees8
Employees8
GLSI Key Statistics
Market cap437.87M
Market cap437.87M
Price-Earnings ratio-20.01
Price-Earnings ratio-20.01
Dividend yield—
Dividend yield—
Average volume472.46K
Average volume472.46K
High today$32.91
High today$32.91
Low today$28.47
Low today$28.47
Open price$29.02
Open price$29.02
Volume646.65K
Volume646.65K
52 Week high$32.91
52 Week high$32.91
52 Week low$7.78
52 Week low$7.78
Stock Snapshot
Greenwich LifeSciences(GLSI) stock is priced at $29.28, giving the company a market capitalization of 437.87M. It carries a P/E multiple of -20.01.
On 2026-01-14, Greenwich LifeSciences(GLSI) stock traded between a low of $28.47 and a high of $32.91. Shares are currently priced at $29.28, which is +2.8% above the low and -11.0% below the high.
Greenwich LifeSciences(GLSI) shares are trading with a volume of 646.65K, against a daily average of 472.46K.
During the past year, Greenwich LifeSciences(GLSI) stock moved between $7.78 at its lowest and $32.91 at its peak.
During the past year, Greenwich LifeSciences(GLSI) stock moved between $7.78 at its lowest and $32.91 at its peak.
People also own
Based on the portfolios of people who own GLSI. This list is generated using Robinhood data, and it’s not a recommendation.